Literature DB >> 10022813

Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.

D S Millar1, K K Ow, C L Paul, P J Russell, P L Molloy, S J Clark.   

Abstract

Glutathione-S-Transferases (GSTs) comprise a family of isoenzymes that provide protection to mammalian cells against electrophilic metabolites of carcinogens and reactive oxygen species. Previous studies have shown that the CpG-rich promoter region of the pi-class gene GSTP1 is methylated at single restriction sites in the majority of prostate cancers. In order to understand the nature of abnormal methylation of the GSTP1 gene in prostate cancer we undertook a detailed analysis of methylation at 131 CpG sites spanning the promoter and body of the gene. Our results show that DNA methylation is not confined to specific CpG sites in the promoter region of the GSTP1 gene but is extensive throughout the CpG island in prostate cancer cells. Furthermore we found that both alleles are abnormally methylated in this region. In normal prostate tissue, the entire CpG island was unmethylated, but extensive methylation was found outside the island in the body of the gene. Loss of GSTP1 expression correlated with DNA methylation of the CpG island in both prostate cancer cell lines and cancer tissues whereas methylation outside the CpG island in normal prostate tissue appeared to have no effect on gene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022813     DOI: 10.1038/sj.onc.1202415

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  62 in total

1.  Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry.

Authors:  Jörg Tost; Philipp Schatz; Matthias Schuster; Kurt Berlin; Ivo Glynne Gut
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

2.  Methylation and epigenetic fidelity.

Authors:  Arthur D Riggs; Zhenggang Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

Review 3.  Flipping the epigenetic switch.

Authors:  Frederick E Domann; Bernard W Futscher
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

Review 4.  In utero oxidative stress epigenetically programs antioxidant defense capacity and adulthood diseases.

Authors:  Rita S Strakovsky; Yuan-Xiang Pan
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

Review 5.  Altered metabolism and mitochondrial genome in prostate cancer.

Authors:  G D Dakubo; R L Parr; L C Costello; R B Franklin; R E Thayer
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

6.  Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma.

Authors:  Queeny K Y Chan; Ui-Soon Khoo; Kelvin Y K Chan; Hextan Y S Ngan; Shan-Shan Li; Pui-Man Chiu; Li-Shan Man; Philip P C Ip; Wei-Cheng Xue; Annie N Y Cheung
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

7.  Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms.

Authors:  Mario Menschikowski; Albert Hagelgans; Eugene Gussakovsky; Heike Kostka; Elena L Paley; Gabriele Siegert
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

8.  DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.

Authors:  Lian Zhang; Qian Zhang; LiLi Li; Zhaohui Wang; Jianming Ying; Yu Fan; Qun He; Tianjing Lv; Wenke Han; Jun Li; Yang Yang; Ben Xu; Lu Wang; Qianling Liu; Yinghao Sun; Yinglu Guo; Qian Tao; Jie Jin
Journal:  J Mol Med (Berl)       Date:  2015-02-05       Impact factor: 4.599

9.  Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.

Authors:  Milan S Geybels; Shanshan Zhao; Chao-Jen Wong; Marina Bibikova; Brandy Klotzle; Michael Wu; Elaine A Ostrander; Jian-Bing Fan; Ziding Feng; Janet L Stanford
Journal:  Prostate       Date:  2015-09-18       Impact factor: 4.104

10.  Differential expression of bikunin (HAI-2/PB), a proposed mediator of glioma invasion, by demethylation treatment.

Authors:  James M Schuster; Maria Longo; Peter S Nelson
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.